Roche Holding AG (RHHBY)
53.09
-0.61
(-1.14%)
USD |
OTCM |
Sep 01, 16:00
Roche Research and Development Expense (Annual) : 14.69B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.69B |
| December 31, 2024 | 14.26B |
| December 31, 2023 | 14.72B |
| December 31, 2022 | 14.71B |
| December 31, 2021 | 14.99B |
| December 31, 2020 | 12.95B |
| December 31, 2019 | 11.76B |
| December 31, 2018 | 11.29B |
| December 31, 2017 | 10.56B |
| December 31, 2016 | 10.05B |
| December 31, 2015 | 9.691B |
| December 31, 2014 | 9.737B |
| December 31, 2013 | 9.384B |
| December 31, 2012 | 9.033B |
| December 31, 2011 | 9.034B |
| December 31, 2010 | 8.615B |
| December 31, 2009 | 8.759B |
| December 31, 2008 | 8.001B |
| Date | Value |
|---|---|
| December 31, 2007 | 6.911B |
| December 31, 2006 | 5.786B |
| December 31, 2005 | 4.550B |
| December 31, 2004 | 4.147B |
| December 31, 2003 | 3.544B |
| December 31, 2002 | 2.736B |
| December 31, 2001 | 2.306B |
| December 31, 2000 | 2.338B |
| December 31, 1999 | 2.515B |
| December 31, 1998 | 2.352B |
| December 31, 1997 | 2.001B |
| December 31, 1996 | 1.972B |
| December 31, 1995 | 1.956B |
| December 31, 1994 | 1.719B |
| December 31, 1993 | 1.464B |
| December 31, 1992 | 1.429B |
| December 31, 1991 | 1.203B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novartis AG | 10.74B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| AstraZeneca PLC | 13.84B |
| Pfizer Inc. | 10.25B |